Section R414-60-12 - Provider-Administered Long-Acting Injectable Antipsychotic Drugs and Drugs for the Treatment of Opioid Use Disorders(1) A provider-administered drug is an outpatient drug, other than a vaccine, that is administered by a health care provider in a physician's office or other outpatient clinical setting.(2) Medicaid may only reimburse for a provider-administered drug if the drug qualifies as a covered outpatient drug in accordance with 42 U.S.C 1396r-8.(3) Selected provider-administered or provider-observed drugs must be dispensed directly to the provider or provider's staff. These include the following: (a) long-acting injectable antipsychotics; and(b) long-acting injectable drugs for the treatment of opioid use disorders.Utah Admin. Code R414-60-12
Adopted by Utah State Bulletin Number 2018-2, effective 1/1/2018Amended by Utah State Bulletin Number 2018-10, effective 5/1/2018Amended by Utah State Bulletin Number 2021-02, effective 1/12/2021Amended by Utah State Bulletin Number 2023-20, effective 10/11/2023